Objective: To explore the effect of sequential treatment with glucocorticoid and tumor necrosis factor-alpha inhibitors in patients with Takayasu arteritis (TA). Materials and Methods: In five patients with TA, the effects of the sequential treatment with prednisone for 5-7 months and then with adalimumab (ADA) + methotrexate (MTX) or infliximab + MTX, or with ADA only, for 12 months on both clinical and laboratory findings were evaluated. Results: All treatments improved both symptoms and laboratory parameters without the development of side-effects. Conclusions: It was hypothesized that MMP-9 and neutrophil gelatinase-associated lipocalin could be markers of the response to the treatments. © 2014 Journal of Pharmacology and Pharmacotherap...
Background/objectives: Takayasu vasculitis (TAK) is a vasculitis affecting the aorta, its primary b...
Background: Biologics are new treatment alternatives in Takayasu Arteritis (TA), although data in ch...
Abstract OBJECTIVES: To explore the efficacy in the long-term and the impact on Health Related Quali...
The objective of this study was to report the long-term use of tumor necrosis factor (TNF) inhibitor...
We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did...
Objective: To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients wit...
Takayasu Arteritis (TAK) is a large-vessel vasculitis that preferentially involves the aorta and its...
Takayasu arteritis (TA) is a rare and idiopathic large-vessel arteritis typically affecting young wo...
Takayasu arteritis (TA) is a chronic inflammatory disease of large arteries which progressively deve...
Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large v...
We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did...
Abstract: Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic va...
Objective: To evaluate the role of an immunosuppressive regimen consisting of azathioprine and predn...
Assessment of the pattern and extent of arterial involvement and measurement of current disease acti...
Objective. To analyse the efficacy and tolerance of infliximab in refractory Takayasu arteritis (TA)...
Background/objectives: Takayasu vasculitis (TAK) is a vasculitis affecting the aorta, its primary b...
Background: Biologics are new treatment alternatives in Takayasu Arteritis (TA), although data in ch...
Abstract OBJECTIVES: To explore the efficacy in the long-term and the impact on Health Related Quali...
The objective of this study was to report the long-term use of tumor necrosis factor (TNF) inhibitor...
We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did...
Objective: To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients wit...
Takayasu Arteritis (TAK) is a large-vessel vasculitis that preferentially involves the aorta and its...
Takayasu arteritis (TA) is a rare and idiopathic large-vessel arteritis typically affecting young wo...
Takayasu arteritis (TA) is a chronic inflammatory disease of large arteries which progressively deve...
Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large v...
We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did...
Abstract: Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic va...
Objective: To evaluate the role of an immunosuppressive regimen consisting of azathioprine and predn...
Assessment of the pattern and extent of arterial involvement and measurement of current disease acti...
Objective. To analyse the efficacy and tolerance of infliximab in refractory Takayasu arteritis (TA)...
Background/objectives: Takayasu vasculitis (TAK) is a vasculitis affecting the aorta, its primary b...
Background: Biologics are new treatment alternatives in Takayasu Arteritis (TA), although data in ch...
Abstract OBJECTIVES: To explore the efficacy in the long-term and the impact on Health Related Quali...